Long-term safety data for dupilumab in a 5-year open- label extension study of adults with moderate-to-severe atopic dermatitis

ACTA DERMATO-VENEREOLOGICA(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要